Back to results
US 11,890,335 B2Granted
ErbB peptide pharmaceutical and vaccine compositions and therapeutic uses thereof for cancer
AssigneesL2 Diagnostics, LLC, Yale University
InventorsMark Mamula, Raymond A. Koski
Life of this patent
Estimating the term…
Abstract
Disclosed herein are peptide-adjuvant pharmaceutical compositions and vaccine compositions that trigger long lasting natural anti-tumor antibodies. Such compositions may be used alone, or in combination with anti-cancer agents, chemotherapeutic agents, anti-PD therapy, chemotherapy, radiation therapy, and surgery, in the prevention and treatment of cancer.
Claims28
A pharmaceutical composition comprising:
- a.) a peptide consisting of a sequence that is at least 90% identical to an amino acid sequence selected from the group consisting of SEQ ID:
- NOs:
- 1-15, wherein the peptide is optionally chemically conjugated to a carrier protein;
- and
- b.) an adjuvant.
2 more elements
A pharmaceutical composition comprising:
- a.) a peptide consisting of an amino acid sequence of any one of SEQ ID:
- NOs:
- 1-15, wherein the peptide is optionally conjugated to a carrier protein;
- and
- b.) an adjuvant.
2 more elements
Dependencies are inferred from the claim text.